BioNTech SE (BNTX)
92.08
-3.92
(-4.08%)
USD |
NASDAQ |
Jun 14, 16:00
92.50
+0.42
(+0.46%)
After-Hours: 20:00
BioNTech Accounts Receivable (Quarterly): 1.771B for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.771B |
December 31, 2023 | 2.383B |
September 30, 2023 | 2.119B |
June 30, 2023 | 2.888B |
March 31, 2023 | 7.034B |
December 31, 2022 | 7.663B |
September 30, 2022 | 7.184B |
June 30, 2022 | 10.85B |
March 31, 2022 | 14.17B |
December 31, 2021 | 14.02B |
September 30, 2021 | 12.30B |
Date | Value |
---|---|
June 30, 2021 | 8.392B |
March 31, 2021 | 2.808B |
December 31, 2020 | 203.56M |
September 30, 2020 | 8.418M |
June 30, 2020 | 8.636M |
March 31, 2020 | 11.37M |
December 31, 2019 | 13.34M |
September 30, 2019 | 9.771M |
June 30, 2019 | 10.07M |
December 31, 2018 | 21.66M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
8.418M
Minimum
Sep 2020
14.17B
Maximum
Mar 2022
4.692B
Average
2.595B
Median
Accounts Receivable (Quarterly) Benchmarks
Pfizer Inc | 10.99B |
Moderna Inc | 137.00M |
GSK PLC | 8.624B |
Cellectis SA | 16.04M |
Biodexa Pharmaceuticals Plc | 0.00 |